The expression of METTL3 is decreased in the hippocampus of AD brain, leading to cognitive impairment, but its expression is increased in microglia, which has the role of promoting neuroinflammation (Zhao et al., 2021; Wen et al., 2022). Here, METTL3 is linked to Alzheimer disease.